Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riverstone HoldingsSGX:AP4 +0.59%62 5-Year Yield-on-Cost % is 6.40 as of Aug. 14, 2026, which is 43% above its 10-year median of 4.46. GuruFocus rates SGX:AP4 with a GF Score™ of 62/100 and a GF Value™ of S$0.87 (Fairly Valued). The stock has 7 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Riverstone Holdings ranks better than 81.96% on this metric.
Riverstone Holdings's yield on cost for the quarter that ended in Dec. 2025 was 6.40.
The historical rank and industry rank for Riverstone Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
SGX:AP4'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.22 Med: 4.46 Max: 42.34
Current: 6.4
During the past 13 years, Riverstone Holdings's highest Yield on Cost was 42.34. The lowest was 0.22. And the median was 4.46.
SGX:AP4's 5-Year Yield-on-Cost % is ranked better than 81.96% of 316
companies
in the Medical Devices & Instruments industry
Industry Median: 2.36
vs SGX:AP4: 6.40
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Riverstone Holdings 5-Year Yield-on-Cost % Related Terms
SGX:AP4 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Riverstone Holdings (SGX:AP4) has a 5-Year Yield-on-Cost % of 6.40 as of Aug. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Riverstone Holdings and its competitors. This is 43% above median its historical median of 4.46. Over the past decade, Riverstone Holdings' 5-Year Yield-on-Cost % has ranged from 0.22 to 42.34. According to the industry distribution chart, Riverstone Holdings ranks #57 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Riverstone Holdings' 5-Year Yield-on-Cost % too high?
Riverstone Holdings' current 5-Year Yield-on-Cost % of 6.40 is 43% above median its 10-year median of 4.46. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 42.34. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.36. Riverstone Holdings' value of 6.40 is 171.2% above this industry median. Based on the distribution chart, Riverstone Holdings ranks #57 out of 316 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Riverstone Holdings has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #57 out of 316 companies for 5-Year Yield-on-Cost %. This places Riverstone Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.36. Riverstone Holdings' value of 6.40 is 171.2% above this benchmark. Historically, Riverstone Holdings' own 5-Year Yield-on-Cost % has ranged from 0.22 to 42.34 over the past decade. While the company's 10-year median is 4.46 vs. the industry median of 2.36, Riverstone Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.36, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current 5-Year Yield-on-Cost % of 6.40 is 171.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Riverstone Holdings and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current 5-Year Yield-on-Cost % is 6.40, which is 43% above median its own 10-year median of 4.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.87, compared to a current price of S$0.86 — trading 1.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.40, which is 43% above median its 10-year median of 4.46 and 171.2% above the Medical Devices & Instruments industry median of 2.36. Riverstone Holdings' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current 5-Year Yield-on-Cost % is 6.40 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued.
The current stock price of S$0.86 is trading 1.7% below its estimated GF Value™ of S$0.87.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
5-Year Yield-on-Cost %: 6.40 (43% above median its 10-year median of 4.46)
GF Value™: S$0.87 vs. price of S$0.86 (1.7% below fair value)
Industry Position: 171.2% above the Medical Devices & Instruments median (#57 of 316)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
62GF Score
Get the complete analysis for SGX:AP4
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
